Rapid Dose Therapeutics Corp. announced changes to its board of directors. Jason Lewis has resigned as a director of the Company. Mr. Lewis will continue in his role as the Company's Senior Vice President, Business Development. In conjunction with the resignation of Mr. Lewis, the Company has appointed a new director. John McKimm has joined the Company as a director and has also been appointed as an independent member of the Company's audit committee to replace Mr. Lewis. Mr. McKimm is currently the Chief Executive Officer of Smart Employee Benefits Inc. (formerly TSXV: SEB), an insurtech company focused on benefits administration technology driving two interrelated revenue streams - benefits solutions and technology services. Mr. McKimm's experience spans over 35 years of serving as a director and an officer of many public and private companies, where he provided operations, investment banking, and corporate finance expertise. This experience covers a range of sectors, including, healthcare, food processing, biotechnology, and retail. He has personally identified, negotiated and executed more than 150 individual merger, acquisition and financing transactions, both as a principal and as an agent. Mr. McKimm possesses a deep knowledge in dealing with emerging and growth companies, specifically with respect to providing specialty services in government funding programs, strategic and financial restructurings, mergers and acquisitions, operational and financial restructuring and the arrangement of financings. Mr. McKimm's experience is global. Mr. McKimm is a graduate of the University of New Brunswick with a Bachelor of Business Administration, and a graduate of the University of Western Ontario with a Masters of Business
Administration and a Bachelor of Laws. Mr. McKimm also has a number of investment industry certifications and designations. He has published on select investment and financial restructuring topics.